135 related articles for article (PubMed ID: 8424669)
1. Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells.
Berczi A; Barabas K; Sizensky JA; Faulk WP
Arch Biochem Biophys; 1993 Jan; 300(1):356-63. PubMed ID: 8424669
[TBL] [Abstract][Full Text] [Related]
2. Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA.
Barabas K; Sizensky JA; Faulk WP
J Biol Chem; 1992 May; 267(13):9437-42. PubMed ID: 1577771
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the anti-cancer activity of transferrin-adriamycin conjugates.
Sizensky JA; Barabas K; Faulk WP
Am J Reprod Immunol; 1992; 27(3-4):163-6. PubMed ID: 1418408
[TBL] [Abstract][Full Text] [Related]
4. Transferrin directed delivery of adriamycin to human cells.
Singh M; Atwal H; Micetich R
Anticancer Res; 1998; 18(3A):1423-7. PubMed ID: 9673350
[TBL] [Abstract][Full Text] [Related]
5. Killing of human tumor cells in culture with adriamycin conjugates of human transferrin.
Yeh CJ; Faulk WP
Clin Immunol Immunopathol; 1984 Jul; 32(1):1-11. PubMed ID: 6329566
[TBL] [Abstract][Full Text] [Related]
6. Transferrin-adriamycin conjugates which inhibit tumor cell proliferation without interaction with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells.
Faulk WP; Barabas K; Sun IL; Crane FL
Biochem Int; 1991 Dec; 25(5):815-22. PubMed ID: 1666508
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptors associate with drug resistance in cancer cells.
Barabas K; Faulk WP
Biochem Biophys Res Commun; 1993 Dec; 197(2):702-8. PubMed ID: 7903529
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of human chronic myeloid leukemia cells insensitivity to adriamycin and mitoxanthrone cytotoxicity by quinidine.
Parekh HK; Advani SH; Chitnis MP
Neoplasma; 1990; 37(6):717-25. PubMed ID: 2274089
[TBL] [Abstract][Full Text] [Related]
9. Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
Chitnis MP; Kamath NS; Parekh HK; Advani SH
Neoplasma; 1991; 38(2):185-91. PubMed ID: 2041578
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
11. Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients.
Faulk WP; Taylor CG; Yeh CJ; McIntyre JA
Mol Biother; 1990 Mar; 2(1):57-60. PubMed ID: 2334538
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.
Szwed M; Jozwiak Z
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():53-63. PubMed ID: 25308442
[TBL] [Abstract][Full Text] [Related]
13. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
Szwed M; Matusiak A; Laroche-Clary A; Robert J; Marszalek I; Jozwiak Z
Toxicol In Vitro; 2014 Mar; 28(2):187-97. PubMed ID: 24055890
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of multidrug-resistant MCF-7 cells to a transferrin-doxorubicin conjugate.
Lemieux P; Pagé M
Anticancer Res; 1994; 14(2A):397-403. PubMed ID: 8017839
[TBL] [Abstract][Full Text] [Related]
15. Characterization of transferrin receptor-dependent GaC-Tf-FeN transport in human leukemic HL60 cells.
Li YQ; Liu B; Zhao CG; Zhang W; Yang BS
Clin Chim Acta; 2006 Apr; 366(1-2):225-32. PubMed ID: 16360136
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of a transferrin-adriamycin conjugate to anthracycline-resistant cells.
Fritzer M; Barabas K; Szüts V; Berczi A; Szekeres T; Faulk WP; Goldenberg H
Int J Cancer; 1992 Oct; 52(4):619-23. PubMed ID: 1399145
[TBL] [Abstract][Full Text] [Related]
17. In vitro cytotoxicity of the conjugate adriamycin with anti-sarcoma monoclonal antibody 19-24.
Mohamed G; Kuzmanoff KM; Stastny JJ; Das Gupta TK
Anticancer Res; 1992; 12(2):529-32. PubMed ID: 1580569
[TBL] [Abstract][Full Text] [Related]
18. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.
Łubgan D; Jóźwiak Z; Grabenbauer GG; Distel LV
Cell Mol Biol Lett; 2009; 14(1):113-27. PubMed ID: 18850074
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the specific binding of bovine transferrin to the human transferrin receptor in K562 cells: evidence for interspecies transferrin internalization.
Tsavaler L; Stein BS; Sussman HH
J Cell Physiol; 1986 Jul; 128(1):1-8. PubMed ID: 3013902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
